Home / Inspections / 1246550

FDA Inspection 1246550 — Catalent Belgium SA

Catalent Belgium SA — FEI 3007647000

The FDA completed an inspection of Catalent Belgium SA on April 7, 2023 in Brussels. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 7, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brussels (Belgium)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1177876 (VAI Fri Aug 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1136201 (VAI Wed Jan 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1093395 (VAI Wed Jun 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1061068 (NAI Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019956 (VAI Fri Jul 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources